Showing results (191-200 of 1,185) with videos related to

Sort By:
Pageof 119
Nephron. Clinical Practice|April 29, 2010
L-type voltage-dependent calcium channel alpha subunit 1C is a novel candidate gene associated with secondary hyperparathyroidism: an application of haplotype-based analysis for multiple linked single nucleotide polymorphismsKeitaro Yokoyama, Mitsuyoshi Urashima, Ichiro Ohkido, et al.
Nephron. Clinical Practice|September 13, 2007
Restenosis following percutaneous renal artery revascularizationGarvan C Kane, Niamh Hambly, Stephen C Textor, et al.
Nephron. Clinical Practice|December 1, 2006
Long-term outcome of paediatric renal transplantation: follow-up of 300 children from 1973 to 2000Lesley Rees, Rukshana Shroff, Carol Hutchinson, et al.
Nephron. Clinical Practice|December 18, 2008
Understanding symptoms in patients with advanced chronic kidney disease managed without dialysis: use of a short patient-completed assessment toolEmma L Murphy, Fliss E M Murtagh, Irene Carey, et al.
Nephron. Clinical Practice|March 17, 2009
Tripterygium wilfordii Hook F treatment for idiopathic refractory nephrotic syndrome in adults: a meta-analysisGaosi Xu, Weiping Tu, Dongfeng Jiang, et al.
Nephron. Clinical Practice|June 23, 2009
UK Renal Registry 11th Annual Report (December 2008): Chapter 12 Epidemiology of Methicillin Resistant Staphylococcus aureus bacteraemia amongst patients receiving Renal Replacement Therapy in England in 2007Richard Fluck, Jennie Wilson, John Davies, et al.
Nephron. Clinical Practice|June 23, 2009
UK Renal Registry 11th Annual Report (December 2008): Chapter 13 Demography of the UK paediatric renal replacement therapy populationMalcolm A Lewis, Joanne Shaw, Manish Sinha, et al.
Nephron. Clinical Practice|June 23, 2009
UK Renal Registry 11th Annual Report (December 2008): Chapter 4 ESRD prevalent rates in 2007 in the UK: national and centre-specific analysesKen Farrington, Alex Hodsman, Anna Casula, et al.
Nephron. Clinical Practice|June 24, 2009
Peroxisome proliferator-activated receptor gamma agonists in kidney disease--future promise, present fearsZhiguo Mao, Albert C M Ong
Nephron. Clinical Practice|June 24, 2009
Truncating mutations in the chloride/proton ClC-5 antiporter gene in Seven Jewish Israeli families with Dent's 1 diseaseDganit Dinour, Miriam Davidovitz, Nomy Levin-Iaina, et al.
Pageof 119